Marko is a structural biochemist with over 20 years of experience in producing complex proteins for structural analysis. He studied biochemistry at the University of Helsinki and did his PhD at European Molecular Biology Laboratory in Heidelberg. He joined the Department of Biochemistry in Cambridge in 1998 and has been leading a research group since 2001. One of the main themes in his research is to understand the structure and function of TGF-beta family growth factors, with particular focus on activins. He runs a core facility providing high quality growth factors and other protein-based tools for stem cell research consortium at the University of Cambridge and this expertise is part of the foundations of Qkine.
Catherine is a biochemist with academic and commercial experience. She earned her PhD in the Biochemistry Department at the University of Cambridge before joining Abcam in 2003, where she was Head of Product Development and Manufacture responsible for in-house antibody design, manufacture and characterisation strategies. Under her leadership the in-house laboratory grew from 4 to 40 staff. She assisted with a successful IPO on AIM in 2005 and was a member of the senior management team. She is currently completing a returners research fellowship at the Wellcome Trust Sanger Institute. Her research interests are protein-protein interactions during cellular recognition and activation events. Alongside her scientific expertise, she brings business development and marketing experience to Qkine.